BIOLASE Technology, Inc. Named as Finalist in the Medical Devices Category for TechAmerica High-Tech Innovation Awards

IRVINE, CA--(Marketwire - May 01, 2012) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, has been named a finalist in the Medical Devices category for the TechAmerica Orange County High-Tech Innovation Awards. Now in its 19th year, this premier business event celebrates excellence and achievement in the region’s technology industry, and honors local companies, individuals and products that drive innovation in Orange County. This year’s winners will be announced at a dinner on June 14, 2012, at the Hilton in Costa Mesa, CA.

“We received nearly 100 nominations including start-up innovators, high-growth companies and established industry players from across Orange County,” said Bob Brunson, director, TechAmerica Orange County. “We congratulate BIOLASE for rising to the finalist rank. This region is home to groundbreaking innovators, including BIOLASE, that continue to influence technology development throughout the rest of the world, and we’re excited to help highlight them.”

Federico Pignatelli, Chairman and CEO, said, “Providing innovative and disruptive technologies that advance the practice of dentistry and medicine with a truly new and biological surgical device that is leading to enhanced outcomes for far superior and safer patient experiences, continues to be our focus at BIOLASE. We are delighted that our Waterlase iPlus™ all-tissue dental laser system is a finalist for innovative product/technology in the medical devices category. The Waterlase iPlus, our flagship laser, is the most advanced laser ever produced for dentistry and, with its tremendous cutting speed and graphical intuitive user interface, addresses a wide range of clinical procedures and can truly change the practice and economics of dentistry.”

For more information, please visit www.techamerica.org/hta19.

About TechAmerica
TechAmerica is the leading voice for the U.S. technology industry -- the driving force behind productivity growth and jobs creation in the United States and the foundation of the global innovation economy. Representing approximately 1,000 member companies of all sizes from the public and commercial sectors of the economy, it is the industry’s largest advocacy organization and is dedicated to helping members’ top and bottom lines. TechAmerica is also the technology industry’s only grassroots-to-global advocacy network, with offices in state capitals around the United States, Washington, D.C., Europe (Brussels) and Asia (Beijing). Learn more about TechAmerica at www.techamerica.org.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World’s leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company’s laser products incorporate 285 patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 19,000 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by BIOLASE management. These forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company’s actual results to differ materially from the statements contained herein, and are described in the Company’s reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and BIOLASE undertakes no obligation to update such statements.